Genaissance Lays Off 10 Percent of Staff Despite 115-Percent Jump in Q3 Revenue

Nov 09, 2004

NEW YORK, Nov. 9 (GenomeWeb News) - Genaissance Pharmaceuticals has laid off 10 percent of its workforce, or around 20 people, as the company continues to seek break-even from operations by the end of 2005, the firm said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Like Sears, But With Cells

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Infertile Mouse No More

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

PGD Growth Spurt

China is embracing preimplantation genetic diagnosis, Nature News reports.

This Week in PLOS

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Main menu